GlassScriptPhysician profile
Andrew G Harrell
NPI 1992739882
$2,128.52
in general payments reported to CMS, 2019-2025
27 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $119 · 2021: $104 · 2022: $473 · 2023: $335 · 2024: $326 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $482.28 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $314.32 | 2019-2024 | Da Vinci Surgical System |
| Organogenesis INC. | $243.93 | 2023-2025 | Puraply, Apligraf |
| Solventum Corporation | $209.30 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Urgo Medical North America, LLC | $171.34 | 2023-2025 | Urgok2, Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Smith+Nephew, INC. | $103.84 | 2020-2023 | Renasys Go V2 Home |
| Abbvie INC. | $86.24 | 2021-2024 | |
| Celgene Corporation | $60.43 | 2019-2020 | |
| Allergan, INC. | $44.91 | 2019-2021 | |
| La Jolla Pharmaceutical Company | $43.47 | 2023-2024 | Xerava, Xacduro |
| Astrazeneca Pharmaceuticals LP | $33.21 | 2019-2023 | Lynparza |
| Tela Bio, INC. | $31.24 | 2020 | |
| Tersera Therapeutics LLC | $27.62 | 2025 | Zoladex |
| Eisai INC. | $26.46 | 2019-2024 | |
| Conmed Corporation | $25.96 | 2025 | Conmed Specimen Retrieval, Airseal |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.64 | 2020 | |
| Merck Sharp & Dohme LLC | $25.20 | 2024 | Keytruda, Lynparza |
| Glaxosmithkline, LLC. | $21.83 | 2024 | Ojjaara |
| Mallinckrodt Hospital Products INC. | $19.59 | 2021 | |
| Stryker Corporation | $18.80 | 2023 | 1788 |
| Ethicon US, LLC | $18.64 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.17 | 2022 | |
| Amgen INC. | $16.36 | 2019 | |
| Janssen Biotech, INC. | $15.61 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.44 | 2019 | |
| Advanced Oxygen Therapy INC. | $15.43 | 2023 | Topical Oxygen Chamber For Extremities |
| Covidien LP | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Harrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.